Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race.
about
50% adherence of patients suffering chronic conditions--where is the evidence?Randomised controlled trial of structured personal care of type 2 diabetes mellitusAdherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter?Patterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes.Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study.How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.Measuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic VeteransAddressing dosing frequency in diabetes: a simple approach to improving adherence to therapy and clinical outcomes.Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.Medication taking and diabetes: a systematic review of the literature.Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD)Impact of dose frequency on compliance and health outcomes: a literature review (1966-2006).Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes.Patient and physician factors associated with adherence to diabetes medications.Correlates of medication nonadherence among Latinos with type 2 diabetes.Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes.Diabetes care today: not everyone should have intensive multipharmacological treatment.A randomized controlled trial on the effect of behavioral strategies for adherence to oral antidiabetic drugs: study protocol.
P2860
Q27010471-A748EF6F-7804-4DE9-B9C5-CA18818BFF48Q28362638-6BF2D848-7A24-4C85-A79F-57EB4C026247Q34164232-8D1ABEAE-52FE-4FA7-8AA7-11D598005934Q34255735-542558CE-E0B6-4889-95BF-8889909E1BFFQ34307167-C81A5130-99A5-451F-BC6E-146F420933E7Q34344393-40B73386-957F-43CF-8FF7-5E7DF20ACD10Q35113964-3383D513-C7FC-4D15-AB0C-DA8CA7ADEC07Q35175088-33486D17-4616-404D-9C74-F5A82296A10FQ36572804-D4C7976D-82CF-4EB4-84C7-139E034BB6A5Q37023520-C4A1E379-C00F-4CA5-BB9A-CC45A83F12B5Q37189184-76980FA4-4AD6-4DC3-9632-EF135568D5E5Q37763151-AFA09613-8502-44C5-8FAD-70C8003A729BQ39970034-A93815D1-7A95-4E88-B4EE-52F9A0FFA8ADQ42641312-3EDF1509-6B96-4075-90D7-5AF8ACA8FF2EQ43804956-D9AAD9E6-B525-4A4F-BA57-B8286686E84BQ44082239-BBC08EC4-783B-44A0-8642-3A1ABB54CE21Q44979688-AEB5ED5D-D5E7-4E90-9372-9E99921A77E4Q49550028-C719729A-A3B2-4AB9-8753-C7646E17A6A5
P2860
Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Sulfonylurea pharmacotherapy r ...... ence of age, gender, and race.
@en
Sulfonylurea pharmacotherapy r ...... ence of age, gender, and race.
@nl
type
label
Sulfonylurea pharmacotherapy r ...... ence of age, gender, and race.
@en
Sulfonylurea pharmacotherapy r ...... ence of age, gender, and race.
@nl
prefLabel
Sulfonylurea pharmacotherapy r ...... ence of age, gender, and race.
@en
Sulfonylurea pharmacotherapy r ...... ence of age, gender, and race.
@nl
P2093
P2860
P1476
Sulfonylurea pharmacotherapy r ...... ence of age, gender, and race.
@en
P2093
C E Reeder
L M Robison
W M Dickson
P2860
P304
531-2, 535, 537-8
P356
10.1177/014572179902500406
P577
1999-07-01T00:00:00Z